Description of the medicine: Grippferonum (Grippferonum)
A mixture of recombinant human α 2 -terferon with polyvinylpyrrolidone, polyethylene oxide and trilon B.
It is proposed as an antiviral drug for the treatment of influenza and other acute respiratory viral diseases.
Assign intranasally to an adult 3 drops (3000 IU) every 3-4 hours; Children from 1 year to 3 years and 3-14 years - 2 drops (2000 IU), respectively, 3 and 4 times a day.
Contraindications: severe forms of allergic diseases, pregnancy.
Form release: solution (drops for the nose) in bottles-droppers 10 ml (10 000 IU / ml).